This is a Validated Antibody Database (VAD) review about cow CD79A, based on 4 published articles (read how Labome selects the articles), using CD79A antibody in all methods. It is aimed to help Labome visitors find the most suited CD79A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD79A synonym: MB-1; B-cell antigen receptor complex-associated protein alpha chain; CD79A antigen (immunoglobulin-associated alpha); CD79a molecule, immunoglobulin-associated alpha; MB-1 membrane glycoprotein; ig-alpha; membrane-bound immunoglobulin-associated protein; surface IgM-associated protein
Bio-Rad
mouse monoclonal (HM57) |
| Bio-Rad CD79A antibody (Serotec, HM57) was used in flow cytometry on human samples . Vet Comp Oncol (2015) ncbi |
mouse monoclonal (HM57) |
| In order to assess the effect of chemotherapy on canine indolent and aggressive lymphoma, Bio-Rad CD79A antibody (Serotec, HM57) was used in flow cytometry on dog samples . Vet Comp Oncol (2015) ncbi |
Abcam
mouse monoclonal (HM57) |
| In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam CD79A antibody (Abcam, ab62650) was used in immunohistochemistry - paraffin section on dog samples at 1:4000 (fig st5) and in immunohistochemistry - paraffin section on rat samples at 1:4000 (fig st5). J Toxicol Pathol (2017) ncbi |
Invitrogen
mouse monoclonal (HM47/A9) |
| In order to evaluate the use of valspodar to treat canine B-cell lymphoma, Invitrogen CD79A antibody (Thermo scientific, Cm067c) was used in immunohistochemistry - paraffin section on dog samples . F1000Res (2015) ncbi |
Articles Reviewed
- Ito D, Childress M, Mason N, Winter A, O BRIEN T, Henson M, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res. 2015;4:42 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments